|
1
|
Luo CL, Li BX, Chen XP, et al: Autophagy
is involved in traumatic brain injury-induced cell death and
contributes to functional outcome deficits in mice. Neuroscience.
184:54–63. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cui C, Cui Y, Gao J, et al:
Neuroprotective effect of ceftriaxone in a rat model of traumatic
brain injury. Neurol Sci. 35:695–700. 2014. View Article : Google Scholar
|
|
3
|
Morganti-Kossmann MC, Rancan M, Stahel PF
and Kossmann T: Inflammatory response in acute traumatic brain
injury: a double-edged sword. Curr Opin Crit Care. 8:101–105. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Feuerstein GZ, Liu T and Barone FC:
Cytokines, inflammation and brain injury: role of tumor necrosis
factor-alpha. Cerebrovasc Brain Metab Rev. 6:341–360.
1994.PubMed/NCBI
|
|
5
|
Aibiki M, Maekawa S, Ogura S, Kinoshita Y,
Kawai N and Yokono S: Effect of moderate hypothermia on systemic
and internal jugular plasma IL-6 levels after traumatic brain
injury in humans. J Neurotrauma. 16:225–232. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Taupin V, Toulmond S, Serrano A, Benavides
J and Zavala F: Increase in IL-6, IL-1 and TNF levels in rat brain
following traumatic lesion: Influence of pre-and post-traumatic
treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine
ligand. J Neuroimmunol. 42:177–185. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Goodman JC, Robertson CS, Grossman RG and
Narayan RK: Elevation of tumor necrosis factor in head injury. J
Neuroimmunol. 30:213–217. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Csuka E, Morganti-Kossmann MC, Lenzlinger
PM, Joller H, Trentz O and Kossmann T: IL-10 levels in
cerebrospinal fluid and serum of patients with severe traumatic
brain injury: relationship to IL-6, TNF-α, TGF-β1 and blood-brain
barrier function. J Neuroimmunol. 101:211–221. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hayakata T, Shiozaki T, Tasaki O, et al:
Changes in CSF S100B and cytokine concentrations in early-phase
severe traumatic brain injury. Shock. 22:102–107. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu KT, Wang YW, Yang JT, Yang YL and Chen
HI: Effect of interleukin-1 on traumatic brain injury-induced
damage to hippocampal neurons. J Neurotrauma. 22:885–895. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Globus MY, Alonso O, Dietrich WD, Busto R
and Ginsberg MD: Glutamate release and free radical production
following brain injury: effects of posttraumatic hypothermia. J
Neurochem. 65:1704–1711. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yi JH and Hazell AS: Excitotoxic
mechanisms and the role of astrocytic glutamate transporters in
traumatic brain injury. Neurochem Int. 48:394–403. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kanai Y and Hediger MA: Primary structure
and functional characterization of a high-affinity glutamate
transporter. Nature. 360:467–471. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pawlak J, Brito V, Küppers E and Beyer C:
Regulation of glutamate transporter GLAST and GLT-1 expression in
astrocytes by estrogen. Brain Res Mol Brain Res. 138:1–7. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tanaka K, Watase K, Manabe T, et al:
Epilepsy and exacerbation of brain injury in mice lacking the
glutamate transporter GLT-1. Science. 276:1699–1702. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tortella FC, Britton P, Williams A, Lu XC
and Newman AH: Neuroprotection (focal ischemia) and neurotoxicity
(electroen-cephalographic) studies in rats with AHN649, a 3-amino
analog of dextromethorphan and low-affinity N-methyl-D-aspartate
antagonist. J Pharmacol Exp Ther. 291:399–408. 1999.PubMed/NCBI
|
|
17
|
Werling LL, Lauterbach EC and Calef U:
Dextromethorphan as a potential neuroprotective agent with unique
mechanisms of action. Neurologist. 13:272–293. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang W, Wang T, Qin L, et al:
Neuroprotective effect of dextromethorphan in the MPTP Parkinson's
disease model: role of NADPH oxidase. FASEB J. 18:589–591.
2004.PubMed/NCBI
|
|
19
|
Duhaime AC, Gennarelli LM and Boardman C:
Neuroprotection by dextromethorphan in acute experimental subdural
hematoma in the rat. J Neurotrauma. 13:79–84. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Beni-Adani L, Gozes I, Cohen Y, et al: A
peptide derived from activity-dependent neuroprotective protein
(ADNP) ameliorates injury response in closed head injury in mice. J
Pharmacol Exp Ther. 296:57–63. 2001.
|
|
21
|
Povlishock JT, Hayes RL, Michel ME and
Mcintosh TK: Workshop on animal models of traumatic brain injury. J
Neurotrauma. 11:723–732. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang CX and Shuaib A: Involvement of
inflammatory cytokines in central nervous system injury. Prog
Neurobiol. 67:161–172. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Allan SM and Rothwell NJ: Cytokines and
acute neurodegeneration. Nat Rev Neurosci. 2:734–744. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Y, Qin L, Li G, et al:
Dextromethorphan protects dopa-minergic neurons against
inflammation-mediated degeneration through inhibition of microglial
activation. J Pharmacol Exp Ther. 305:212–218. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao HM, Liu B, Zhang W and Hong JS: Novel
anti-inflammatory therapy for Parkinson's disease. Trends Pharmacol
Sci. 24:395–401. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tortella FC, Pellicano M and Bowery NG:
Dextromethorphan and neuromodulation: old drug coughs up new
activities. Trends Pharmacol Sci. 10:501–507. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Klette KL, Lin Y, Clapp LE, DeCoster MA,
Moreton J and Tortella FC: Neuroprotective sigma ligands attenuate
NMDA and trans-ACPD-induced calcium signaling in rat primary
neurons. Brain Res. 756:231–240. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Carpenter CL, Marks SS, Watson DL and
Greenberg DA: Dextromethorphan and dextrorphan as calcium channel
antagonists. Brain Res. 439:372–375. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Feng S, Xu Z, Liu W, Li Y, Deng Y and Xu
B: Preventive effects of dextromethorphan on methylmercury-induced
glutamate dyshomeostasis and oxidative damage in rat cerebral
cortex. Biol Trace Elem Res. 159:332–345. 2014. View Article : Google Scholar : PubMed/NCBI
|
